Product phospholipids -lipids-for-drug-delivery

Home > products > phospholipids > lipids-for-drug-delivery

Catalog	name	Description	price
R-C-7004	Neutral Liposomes (Lyophosome-PEGylated)(PC:Chol:PEG2000-DOPE (65:30:5 molar ratio))	Neutral Liposomes(Lyophosome-PEGylated)(PC:Chol:PEG2000-DOPE(65:30:5 molar ratio)),PEG2000-DOPE provides a spatially stable layer that reduces plasma protein adsorption and prolongs the half-life of liposomes in the bloodstream.The PEG coating forms a hydrophilic barrier,significantly reducing immune system clearance,making it suitable for targeted delivery research.	price>
R-C-7005	Neutral Liposomes (Lyophosome-PEGylated)(DOPC:Chol:PEG2000-DOPE (65:30:5 molar ratio))	DOPC:Chol:PEG2000-DOPE (65:30:5 molar ratio),PEG2000-DOPE provides a spatially stable layer that reduces plasma protein adsorption and prolongs the half-life of liposomes in the bloodstream.The PEG coating forms a hydrophilic barrier,significantly reducing immune system clearance,making it suitable for targeted delivery research.	price>
R-C-7006	Anionic Liposomes (Lyophosome-PEGylated)(DSPC:Chol:DSPG:PEG2000-DSPE (60:30:5:5 molar ratio))	Anionic Liposomes(Lyophosome-PEGylated)(DSPC:Chol:DSPG:PEG2000-DSPE (60:30:5:5 molar ratio)),Polyethylene glycol(PEG)is a spatially stable hydrophilic polymer that has been used to enhance the stability of liposomes and prolong their circulation time in the blood.Adding PEG to neutral liposomes can protect them from the influence of circulating proteins,improve their plasma clearance rate,and enhance their therapeutic efficacy.	price>
R-C-7007	Anionic Liposomes (Lyophosome-PEGylated)(DOPC:Chol:DOPG:PEG2000-DOPE (60:30:5:5 molar ratio))	Anionic Liposomes (Lyophosome-PEGylated)(DOPC:Chol:DOPG:PEG2000-DOPE(60:30:5:5 molar ratio)),Polyethylene glycol(PEG)is a spatially stable hydrophilic polymer that has been used to enhance the stability of liposomes and prolong their circulation time in the blood. Adding PEG to neutral liposomes can protect them from the influence of circulating proteins,improve their plasma clearance rate,and enhance their therapeutic efficacy.	price>
R-C-7008	Anionic Liposomes (Lyophosome-PEGylated)(DSPC:Chol:DSPS:PEG2000-DSPE (60:30:5:5 molar ratio))	Anionic Liposomes(Lyophosome-PEGylated)(DSPC:Chol:DSPS:PEG2000-DSPE (60:30:5:5 molar ratio)),Polyethylene glycol(PEG)is a spatially stable hydrophilic polymer that has been used to enhance the stability of liposomes and prolong their circulation time in the blood. Adding PEG to neutral liposomes can protect them from the influence of circulating proteins,improve their plasma clearance rate,and enhance their therapeutic efficacy.	price>
R-C-7009	Anionic Liposomes (Lyophosome-PEGylated)(DOPC:Chol:DOPS:PEG2000-DOPE (60:30:5:5 molar ratio))	Anionic Liposomes (Lyophosome-PEGylated)(DOPC:Chol:DOPS:PEG2000-DOPE(60:30:5:5 molar ratio)),Polyethylene glycol(PEG)is a spatially stable hydrophilic polymer that has been used to enhance the stability of liposomes and prolong their circulation time in the blood.Adding PEG to neutral liposomes can protect them from the influence of circulating proteins,improve their plasma clearance rate,and enhance their therapeutic efficacy.	price>
R-C-7010	Cationic Liposomes (Lyophosome-PEGylated)(DSPC:Chol:DSTAP:PEG2000-DSPE (60:30:5:5 molar ratio))	Cationic Liposomes (Lyophosome-PEGylated)(DSPC:Chol:DSTAP:PEG2000-DSPE (60:30:5:5 molar ratio)),Cationic liposomes interact with negatively charged glycoproteins on the cell surface, thereby increasing the affinity and residence time with the target cells,resulting in increased drug delivery.Conventional liposomal formulations reduced the toxicity of compounds in vivo, through modifying pharmacokinetics and biodistribution to enhance drug delivery to diseased tissue in comparison to free drug.	price>
R-C-7011	Cationic Liposomes (Lyophosome-PEGylated)(DOPC:Chol:DOTAP:PEG2000-DOPE (60:30:5:5 molar ratio))	Cationic Liposomes (Lyophosome-PEGylated)(DOPC:Chol:DOTAP:PEG2000-DOPE (60:30:5:5 molar ratio)),Cationic liposomes interact with negatively charged glycoproteins on the cell surface, thereby increasing the affinity and residence time with the target cells,resulting in increased drug delivery.Conventional liposomal formulations reduced the toxicity of compounds in vivo, through modifying pharmacokinetics and biodistribution to enhance drug delivery to diseased tissue in comparison to free drug.	price>
R-C-7012	Lyophosome made from Unsaturated Phosphatidylcholine (PC)(100% 14:1 (Δ9-Cis) PC)	Lyophosome made from Unsaturated Phosphatidylcholine(PC)(100% 14:1 (Δ9-Cis)PC)Completely composed of 14:1(Δ9-Cis)PC, without cholesterol or other co lipids,the phosphatidylcholine(PC)head group is electrically neutral, and the surface charge of the liposome is close to neutral.	price>
R-C-7013	Lyophosome made from Unsaturated Phosphatidylcholine(PC)(100% 14:1(Δ9-Trans)PC)	Lyophosome made from Unsaturated Phosphatidylcholine(PC)(100% 14:1(Δ9-Trans)PC),Lyophosome made from Unsaturated Phosphatidylcholine(PC)(100% 14:1(Δ9-Trans)PC),Unsaturated phosphatidylcholine freeze-dried liposomes(Lyosomes)made from 100% 14:1(Δ9-trans)PC exhibit electrical neutrality at physiological pH(as PC is a zwitterionic phospholipid),reducing non-specific binding.Unsaturated fatty acid chains(including double bonds)enhance the fusion ability between liposomes and cell membranes,promoting the release of contents.	price>

...